Importantly, Tamoxifen failed to acquire unspecific effects in both TP53-engineered models on the level of tumor-associated macrophage recruitment (Supplementary Fig. S5A, B), vessel formation (Supplementary Fig. S5C, D) and proliferation (Supplementary Fig. S5E, F). The gene discussed is TP53; the disease is neoplasm.